BioCentury
ARTICLE | Clinical News

Surfaxin lucinactant regulatory update

July 6, 2009 7:00 AM UTC

Discovery Laboratories Inc. (NASDAQ:DSCO), Warrington, Pa. Product: Surfaxin lucinactant Business: Pulmonary Discovery Labs said that it is unlikely to gain FDA approval of Surfaxin lucinactant to pr...